# RA Capital Management

> RA Capital Management invests in healthcare and life-sciences companies across public and private markets. It led Estuary Biotherapeutics’ $93 million Series A announced on October 16, 2026. Source: https://www.racap.com/about and https://estuarybio.com/news/estuary-series-a

## Profile

- **Stage-based planning range:** $100K–$1M
- **Check-size evidence basis:** estimated
- **Founded:** N/A
- **Headquarters:** N/A
- **AUM:** N/A
- **Rounds they lead:** N/A
- **Rounds they invest:** N/A
- **Last verified:** 2026-10-17

## Links

- [Website](https://www.racap.com/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 17, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/ra-capital-management
